Galapagos NV ADR (GLPG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GLPG | GRAL | VRDN | ||
| Company | Galapagos NV ADR | Grail Inc | Viridian Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 29.00 | 48.51 | 18.71 | ||
| High | 30.43 | 51.48 | 19.84 | ||
| Low | 28.98 | 47.90 | 18.49 | ||
| Latest | 30.35 | 51.22 | 19.10 | ||
| Change | +1.51 | +4.32 | +0.57 | ||
| % Change | +5.24% | +9.21% | +3.08% | ||
| Volume | 94,223 | 253,929 | 2,069,051 | ||
| 20-Day Average Volume | 177,277 | 903,690 | 2,002,075 | ||
| Previous Close | 28.84 | 46.90 | 18.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.78 | 48.68 | 27.45 | ||
| 20-Day Raw Stochastic | 28.41% | 64.16% | 19.97% | ||
| 20-Day Relative Strength | 41.63 | 41.43 | 28.60 | ||
| Weighted Alpha | +15.33 | +135.32 | +46.29 | ||
| Today's Opinion | 40% Sell | 56% Sell | 40% Sell | ||
| Previous Opinion | 40% Sell | 72% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 24% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.76% since 03/24/26 | +4.65% since 03/24/26 | -27.44% since 03/24/26 | ||
| Low | 28.70 on 03/30/26 | 45.79 on 03/30/26 | 16.97 on 03/30/26 | ||
| High | 30.86 on 03/25/26 | 53.44 on 03/26/26 | 28.59 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | -9.91% since 02/27/26 | -4.36% since 02/27/26 | -32.85% since 02/27/26 | ||
| Low | 28.70 on 03/30/26 | 41.53 on 03/13/26 | 16.97 on 03/30/26 | ||
| High | 34.42 on 03/05/26 | 56.15 on 03/04/26 | 30.79 on 03/05/26 | ||
| 3-Month | |||||
| %Chg | -8.19% since 12/26/25 | -44.42% since 12/26/25 | -38.11% since 12/26/25 | ||
| Low | 28.70 on 03/30/26 | 41.50 on 02/23/26 | 16.97 on 03/30/26 | ||
| High | 36.24 on 02/24/26 | 118.84 on 01/22/26 | 34.29 on 01/14/26 | ||
| 6-Month | |||||
| %Chg | -10.23% since 09/26/25 | +2.11% since 09/26/25 | -2.28% since 09/26/25 | ||
| Low | 28.70 on 03/30/26 | 41.50 on 02/23/26 | 16.97 on 03/30/26 | ||
| High | 37.78 on 10/03/25 | 118.84 on 01/22/26 | 34.29 on 01/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,900,470 | 1,923,838 | 1,893,896 | ||
| Shares Outstanding, K | 65,897 | 41,020 | 102,207 | ||
| Annual Sales | 1,258,400,000 | 147,170,000 | 70,850,000 | ||
| Annual Net Income | 363,050,000 | -408,350,000 | -342,600,000 | ||
| Last Quarter Sales | 78,990,000 | 43,600,000 | 130,000 | ||
| Last Quarter Net Income | -161,610,000 | -99,180,000 | -120,360,000 | ||
| 60-Month Beta | 0.26 | 5.21 | 1.00 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.47 on 04/23/25 | -2.44 on 02/19/26 | -1.08 on 02/26/26 | ||
| Latest Earnings Date | 04/22/26 | 05/12/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||